Esteve Huayi Pharmaceutical Co., Ltd., Shaoxing, China – FDA Inspections

Inspection records and compliance data for Esteve Huayi Pharmaceutical Co., Ltd. in Shaoxing. 4 FDA inspections on record, 1 Form 483, last inspected March 14, 2025.

Company Profile

This profile covers Esteve Huayi Pharmaceutical Co., Ltd. based in Shaoxing, China.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 2
NAI: 1
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected January 6, 2012. Last inspected March 14, 2025.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
March 14, 2025	Not classified	Human Drugs	1267078
January 23, 2019	VAI	Human Drugs · Drug Quality Assurance	1078945
March 20, 2015	NAI	Human Drugs · Drug Quality Assurance	925940
January 6, 2012	VAI	Human Drugs · Drug Quality Assurance	765937

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Suzhou Lixin Pharmaceutical Co. Ltd.

Qingdao Jiulong Biopharmaceutical Co. Ltd.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Tien (Tianjin) Pharmaceutical Co., Ltd.

Guangdong Blue Treasure Pharmaceuticals Co. Ltd.

BrightGene Pharmaceutical Co., Ltd.

Shandong Lixin Pharmaceutical Co., Ltd.

NANJING HAIRUN PHARMACEUTICAL CO., LTD.

Qilu Pharmaceutical Co., Ltd. (Laoling Site)

SK Biotek Ireland Ltd.